UBM Live announces CPhI Pharma Awards winners

Published: 16-Oct-2012

Organisers impressed with number and quality of entries


The winners of the Gold, Silver and Bronze CPhI Pharma Awards, formerly known as the Innovation Awards, were announced on the first night of the show in Madrid on 9 October 2012.

The category Best Innovation recognises innovations that are viable on a commercial scale. The category was expanded for 2012 to encourage entries across the formulation, drug delivery, chemical manufacturing of APIs and intermediates, and biomanufacturing of biopharmaceuticals and intermediates sectors.

The winner of the Gold Award was Haemopharm Healthcare’s NIV needle free vial closure. Merck Millipore took the Silver Award for its bimodal silica used as a drug delivery platform, while BioClin’s Multi-Oral Remin remineralisation gel for application in the oral cavity took the Bronze. The judging panel included representatives from CU Chemie Uetikon, Pliva and Merck Millipore.

Two further awards focused on sustainability: Best Sustainable Stand Design, and the newly introduced Best Sustainable Packaging.

‘Sustainability has been a key driver of our business ethos at UBM Live for quite some time,’ said Andrew Pert, Brand Director. ‘As such, we wanted to ensure that this commitment to sustainability is evident in not only the set-up, but also through our awards series so it is fitting that two of the 2012 CPhI Pharma Award categories celebrate and encourage sustainability.

The Best Sustainable Stand Design category recognised one exhibitor who has fully taken the UBM philosophy of minimising impact on the environment into consideration through its presence at the event, and was awarded to Solvias. Also in line with the UBM commitment to sustainability, the Best Sustainable Packaging was won by MWV.

  • Companies:
  • Merck Electronics KGaA
  • BioClin BV
  • Informa
See more

You may also like

Manufacturing

Faster CDMO growth in 2025 predicted and industry not in favour of BIOSECURE Act, states CPHI Milan survey

Read more
CPHI Milan returns next month at a pivotal moment as contract services growth is predicted to accelerate in 2025

Trending Articles

  1. Lonza Capsules & Health Ingredients expands capsule manufacturing capacity in India and China New capsule manufacturing lines added at Lonza Capsules & Health Ingredients (CHI) facilities in Rewari (IN) and Suzhou (CN), highlighting the long-term strategic commitment to the business and the APAC region
  2. You need to be a subscriber to read this article.
    Click here to find out more.
    Industrial data mastery: navigating the 2025 landscape As industrial manufacturers contend with the ever-increasing volume and variety of operational data, the year ahead promises both complexity and opportunity
  3. Resolving capping issues in tablet manufacturing Natoli explores the various causes of capping and the methods to prevent it
  4. Novo Holdings completes acquisition of Catalent Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark
  5. Newcells Biotech raises additional funding from investors Newcells Biotech, a leading drug discovery partner specialising in the development of in vitro models and bespoke assay services to improve the prediction of in vivo human outcomes, has raised a further £1.2m from existing investors Mercia Ventures, Northstar Ventures and North East Finance

Upcoming event

EMPQ Essentials and Real-World Strategies for Successful Cleanroom Qualifications

16 January 2025 | Virtual See all

You may also like

Manufacturing

Faster CDMO growth in 2025 predicted and industry not in favour of BIOSECURE Act, states CPHI Milan survey

CPHI Milan returns next month at a pivotal moment as contract services growth is predicted to accelerate in 2025
Pharmaceutical

CPHI Milan announces the finalists for 14 categories of the Pharma Awards

Awards for future leaders, women of the year and those at the heart of pharma will be handed out at the CPHI Pharma Awards ceremony
Ingredients

CPHI Milan Annual Report 2024

Ahead of next month’s CPHI Milan — where the industry is expected to turnout in record numbers with a staggering 62,000 pharma executives expected from more than 100 countries — Manufacturing Chemist got a sneak preview of the CPHI Annual Reports Excipients Analysis featuring Ian Moore’s (former Chair of the IPEC Europe GMP Committee) personal predictions for the year ahead
Research & Development

Quibim partners with Merck KGaA to develop imaging-based diagnostics

Quibim and Merck KGaA have partnered to develop diagnostic tools which will fortify the implementation of personalised medicine
Packaging

Contract packaging predicted to see high growth in 2024 ahead of Pharmapack Europe

Ninety four per cent of the industry are either "highly positive" or "moderately positive" about growth prospects for 2024
Packaging

Pharmapack: sustainability collaborations essential to mitigate scope 3 supply chain issues

Ahead of this month’s Pharmapack Europe 2024, Dr Kevin Robinson (KSR) spoke with Silvia Forroova (SF), Director of Partnerships and Sustainability at Informa Markets to find out how the event is helping the industry centralise debate and bring together different stakeholders in the supply chain to accelerate sustainable initiatives
Packaging

Global confidence in drug delivery innovation remains at record high, says Pharmapack

France sees biggest rise in delivery innovation score ahead of Pharmapack Europe 2024
Subscribe now